Patterns and Predictors of First-Line Taxane Use in Patients with Metastatic Triple-Negative Breast Cancer in US Clinical Practice

por O’Shaughnessy, Joyce, Emens, Leisha A., Chui, Stephen Y., Wang, Wei, Russell, Kenneth, Lin, Shih-Wen, Avile, Carlos Flores, Luhn, Patricia, Schneeweiss, Andreas
Publicado 2021

Association of baseline systemic corticosteroid use with overall survival and time to next treatment in patients receiving immune checkpoint inhibitor therapy in real-world US onco...

por Drakaki, Alexandra, Dhillon, Preet K, Wakelee, Heather, Chui, Stephen Y, Shim, Jinjoo, Kent, Matthew, Degaonkar, Viraj, Hoang, Tien, McNally, Virginia, Luhn, Patricia, Gutzmer, Ralf
Publicado 2020

Patient-reported outcomes from a randomized trial of neoadjuvant atezolizumab-chemotherapy in early triple-negative breast cancer

por Barrios, Carlos H., Saji, Shigehira, Harbeck, Nadia, Zhang, Hong, Jung, Kyung H., Patel, Sheetal, Patel, Shilpen, Duc, Anh Nguyen, Liste-Hermoso, Mario, Chui, Stephen Y., Mittendorf, Elizabeth A.
Publicado 2022

Intratumor mapping of intracellular water lifetime: metabolic images of breast cancer?

por Springer, Charles S, Li, Xin, Tudorica, Luminita A, Oh, Karen Y, Roy, Nicole, Chui, Stephen Y-C, Naik, Arpana M, Holtorf, Megan L, Afzal, Aneela, Rooney, William D, Huang, Wei
Publicado 2014

Early Prediction and Evaluation of Breast Cancer Response to Neoadjuvant Chemotherapy Using Quantitative DCE-MRI()

por Tudorica, Alina, Oh, Karen Y, Chui, Stephen Y-C, Roy, Nicole, Troxell, Megan L, Naik, Arpana, Kemmer, Kathleen A, Chen, Yiyi, Holtorf, Megan L, Afzal, Aneela, Springer, Charles S, Li, Xin, Huang, Wei
Publicado 2016

DCE-MRI Texture Features for Early Prediction of Breast Cancer Therapy Response

por Thibault, Guillaume, Tudorica, Alina, Afzal, Aneela, Chui, Stephen Y-C., Naik, Arpana, Troxell, Megan L., Kemmer, Kathleen A., Oh, Karen Y., Roy, Nicole, Jafarian, Neda, Holtorf, Megan L., Huang, Wei, Song, Xubo
Publicado 2017

Atezolizumab and nab-Paclitaxel in Advanced Triple-Negative Breast Cancer: Biomarker Evaluation of the IMpassion130 Study

por Emens, Leisha A, Molinero, Luciana, Loi, Sherene, Rugo, Hope S, Schneeweiss, Andreas, Diéras, Véronique, Iwata, Hiroji, Barrios, Carlos H, Nechaeva, Marina, Nguyen-Duc, Anh, Chui, Stephen Y, Husain, Amreen, Winer, Eric P, Adams, Sylvia, Schmid, Peter
Publicado 2021

PD-L1 Immunohistochemistry Assay Comparison in Atezolizumab Plus nab-Paclitaxel–Treated Advanced Triple-Negative Breast Cancer

por Rugo, Hope S, Loi, Sherene, Adams, Sylvia, Schmid, Peter, Schneeweiss, Andreas, Barrios, Carlos H, Iwata, Hiroji, Diéras, Véronique, Winer, Eric P, Kockx, Mark M, Peeters, Dieter, Chui, Stephen Y, Lin, Jennifer C, Nguyen-Duc, Anh, Viale, Giuseppe, Molinero, Luciana, Emens, Leisha A
Publicado 2021